Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine
redOrbit - 1 minute agoRECHOVOT, Israel, Dec. 7 /PRNewswire/ -- 60 people, males and females, aged 18-49, participated in the trialThe antibodies generated by the vaccine specifically identified several strains of influenza, including the swine flu strainBiondVax's CEO Dr.




